Dravet Syndrome Clinical Trials in Ann Arbor, Michigan
3 recruitingAnn Arbor, Michigan
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Dravet Syndrome
Ionis Pharmaceuticals, Inc.32 enrolled1 locationNCT07531745
Recruiting
Phase 3
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Dravet Syndrome
Stoke Therapeutics, Inc170 enrolled61 locationsNCT06872125
Recruiting
Phase 3
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Dravet Syndrome
Epygenix150 enrolled46 locationsNCT04462770